Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Lancet Neurol. 2015 Jun 29;14(8):804–813. doi: 10.1016/S1474-4422(15)00135-0

Figure 3. Comparison between ADAD and Stage-0 older controls.

Figure 3

We compared the mixed model estimates for the neuroimaging and clinical markers in ADAD to cross-section data from “Stage-0” older controls who were selected to have normal PiB, FDG, age-corrected hippocampal W-score and cognition. Significant (p<0·01) increases in ADAD are indicated in red while significant decreases are indicated in blue.